Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
-
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
-
Birchtech Reports Third Quarter 2025 Financial Results
-
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
-
Hudson Technologies Appoints Kenneth Gaglione as Chairman of the Board, President and Chief Executive Officer
-
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
-
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
-
SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
-
eGain to Participate in the Roth Technology Conference on November 19, 2025
-
Fluent Announces Third Quarter 2025 Financial Results; Commerce Media Solutions Annual Revenue Run Rate Exceeds $85 Million and Represents 40% of Consolidated Revenue
-
CapsoVision Reports Third Quarter 2025 Financial Results
-
Nasdaq Executives to Present at Upcoming Investor Conferences
-
Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million
-
Profound Medical Reports Strong Third Quarter 2025 Financial Results
-
Shimmick Corporation Announces Third Quarter 2025 Results
-
RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update
-
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
-
Xos Extends Profitability Streak with Strong Q3 2025 Performance and Positive Operating Cash Flow
-
Jefferson Capital Reports Third Quarter 2025 Results
-
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
-
Red Cat Holdings Reports Q3 2025 Revenue Growth of 646% Y/Y Sequential Quarterly Revenue Growth of 200%; Guides Q4 Revenue to 1455% Y/Y; FY 2025 Revenue Guidance to 124% Y/Y, Beating Q3 Revenue Consen
-
AirJoule Technologies (NASDAQ: AIRJ) Announces Third Quarter 2025 Results and Provides Business Update
-
Aterian Reports 2025 Third Quarter Financial Results and Reiterates Guidance
-
zSpace Reports Third Quarter 2025 Financial Results
-
The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
-
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025
-
Flux Power Reports Fiscal Year 2026 First Quarter Financial Results
-
Expion360 Reports Third Quarter 2025 Financial and Operational Results
-
Intchains Group Limited Reports Third Quarter and Nine Months 2025 Financial Results
-
Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
-
Astera Labs Announces Fourth Quarter 2025 Financial Conference Participation
-
Robinhood Markets, Inc. Reports October 2025 Operating Data
-
Maris-Tech Enters Quantum Navigation Field with Strategic Agreement to Develop Quantum-Based Gyroscope to Replace GPS Navigation
-
nCino Announces Timing of its Third Quarter Fiscal Year 2026 Financial Results Conference Call
-
ORIC® Pharmaceuticals Announces Completion of Dose Exploration Portion of ORIC-944 Phase 1b Clinical Trial and Continues to Demonstrate Potential Best-in-Class Efficacy and Safety
-
Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration
-
Rekor Systems Reports Record Third Quarter 2025 Financial Results
-
BioStem Technologies Reports Third Quarter 2025 Financial Results
-
Credit Acceptance Announces Completion of $500.0 Million Asset-Backed Financing
-
BioStem Technologies Announces Filing of Restated Financial Statements
-
Relmada Therapeutics Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates
-
Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
The Metals Company Announces Third Quarter 2025 Corporate Update
-
Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Fossil Group, Inc. Reports Third Quarter 2025 Financial Results
-
Applied Materials Announces Fourth Quarter and Fiscal Year 2025 Results
-
Freehold Royalties Announces Third Quarter 2025 Results

